- “Canagliflozin + Metformin Tablets” already exists in your wishlist
In Stock
Imatinib Mesylate Tablets
Imatinib Mesylate Tablets 100mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • Updated 16 October 2026
Important: This is an educational guide, not a prescription or a substitute for advice from your cancer specialist.
Product Introduction
Imatinib mesylate is a targeted anticancer medicine. Imatib 100 Tablet contains imatinib mesylate 100 mg and is marketed by Cipla Ltd. It is used for selected cancers and blood or bone-marrow disorders when prescribed by a specialist.
This medicine is prescription-only. The appropriate dose and duration depend on the diagnosis, test results, response to treatment and tolerability. A 100 mg tablet strength does not mean every patient should take one tablet daily.
1. Uses
May be prescribed for selected cases of chronic myeloid leukaemia (CML), acute lymphoblastic leukaemia (ALL), gastrointestinal stromal tumours (GIST), dermatofibrosarcoma protuberans and certain forms of systemic mastocytosis.
Not every patient with these conditions is suitable for imatinib. Use depends on the precise diagnosis and the treating specialist’s assessment.
2. Benefits
Targets abnormal signalling proteins involved in the growth of certain cancer cells.
Can help slow or stop the growth of sensitive cancer cells and support disease control in patients for whom imatinib is appropriate.
Benefits vary by diagnosis and individual response. Regular specialist review and laboratory monitoring are essential.
3. Side Effects
Common side effects include swelling or fluid retention (edema), nausea, vomiting, diarrhoea, abdominal pain, muscle cramps, muscle/joint/bone pain, rash and tiredness.
Seek urgent medical care for difficulty breathing or facial/throat swelling; severe or rapidly worsening swelling or rapid weight gain; unusual bleeding or bruising; fever or signs of infection; yellow skin/eyes or dark urine; severe abdominal pain; or a severe blistering/peeling rash.
Serious effects can include low blood-cell counts, liver problems, significant fluid retention, bleeding and severe skin reactions. Tell the treating team promptly about new or worsening symptoms.
4. Safety Advice
Take only under specialist supervision. Do not start, stop, skip or change the dose without the prescriber’s instructions.
Blood counts, liver function and other tests may be needed before and during treatment. Keep all appointments and report symptoms promptly.
Tell the doctor if you have liver or kidney disease, heart problems, a history of fluid retention, or an ongoing infection.
Pregnancy: imatinib can harm an unborn baby. Tell the specialist if pregnant, planning pregnancy or if pregnancy occurs. Discuss effective contraception with the treating team.
Breastfeeding is generally not recommended during treatment. Ask the specialist for individual advice.
Do not drive or operate machinery if you experience dizziness, drowsiness or blurred vision. Ask your doctor about alcohol and sun protection; the medicine may make skin more sensitive to sunlight.
Store below 30°C as stated on the linked product page, and keep out of reach of children. Follow the package leaflet if its storage instructions differ.
5. How It Works
Imatinib inhibits certain tyrosine kinases, including BCR-ABL and other target kinases in particular diseases. Blocking these signals can reduce the growth and survival of cells that depend on them.
6. How to Use
Follow the exact dose and schedule prescribed for your diagnosis. Do not use this guide to decide how many tablets to take.
Take with or after food and a full glass of water, at the time(s) advised by your specialist.
Swallow the tablet as directed in the product leaflet. Do not chew, crush or break it unless a pharmacist or treating clinician gives you specific approved instructions.
If swallowing is difficult, ask the pharmacist or treating team for safe instructions. Do not improvise.
If you miss a dose or vomit after taking it, contact your treatment team or follow the patient leaflet. Do not double a dose unless specifically instructed.
Do not discontinue treatment because you feel better. Treatment duration is determined by the specialist.
7. Quick Tips
Keep a current list of all prescription medicines, over-the-counter medicines, vitamins and herbal products and share it with the oncology team.
Report rapid weight gain, swelling, shortness of breath, unusual bruising/bleeding, fever or possible liver symptoms promptly.
Take the medicine with food and a full glass of water, and keep a regular routine.
Ask the care team which tests and monitoring schedule apply to you. Use sun protection if advised.
8. Drug Interactions
Imatinib interacts with many medicines. Examples include atorvastatin, ranolazine, pimozide, vinblastine, vincristine, warfarin, rifampicin, certain antifungals, antibiotics, seizure medicines, some antiviral medicines and St John’s wort.
Do not start or stop any medicine, supplement or herbal product without checking with the prescriber or pharmacist. The examples above are not a complete interaction list; a medication review is important.
Medical Disclaimer
This document is for general educational purposes only and is not a substitute for medical advice, diagnosis or treatment. Imatinib is a specialist-prescribed anticancer medicine. Do not use this guide to select a dose or make treatment decisions. Always follow the current package leaflet and the instructions of your oncologist or pharmacist. In an emergency, seek urgent medical care.
| Product Name | Imatinib Mesylate Tablets |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 100mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
